Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profiles

International Journal of Biological Sciences

Volumn 4, Issue 6, 2008, Pages 368-378

  Distaso, Angela ^a   Abatangelo, Luca ^a   Maglietta, Rosalia ^a   Creanza, Teresa Maria ^a   Piepoli, Ada ^b   Carella, Massimo ^b   D'Addabbo, Annarita ^a   Ancona, Nicola ^a  

^a INSTITUTE OF INTELLIGENT SYSTEMS FOR AUTOMATION   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Colon cancer; Gene expression; Machine learning; Microarray; Pathway analysis; Prediction accuracy

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; PROTEIN MAD2; PROTEIN P53; REPLICATION FACTOR A; VASCULOTROPIN;

ARTICLE; BIOASSAY; CARCINOGENESIS; CELL CYCLE ARREST; COLON CANCER; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; HUMAN; PHENOTYPE;

EID: 54949123846     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4.368     Document Type: Article

References (69)

1. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene-expression patterns with a complementary-DNA microarray. Science 1995, 270:467-470.
2. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring. Science 1999, 286:531-537.
3. Barrier A, Boelle PY, Roser F, Gregg J, Tse C, Brault D, Lacaine F, Houry S, Huguier M, Franc B, Flahault A, Lemoine A, Dudoit S: Stage II Colon Cancer Prognosis Prediction by Tumor Gene Expression Profiling. J Clin Oncol 2006, 24(29):4685-4691.
4. Storey J, Tibshirani R: Statistical significance for genomwide studies. Proc Natl Acad Sci 2003, 100:9440-9445.
5. Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J, Davis A, Dolinski K, Dwight S, Eppig J, Harris M, Hill D, Issel-Tarver L, Kasarskis A, Lewis S, Matese J, Richardson J, Ringwald M, Rubin G, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29.
6. Kanehisa M, Goto S, Kawashima S, Nakaya A: The KEGG databases at GenomeNet. Nucleic Acids Res 2002, 30:42-46.
7. Khatri P, Draghici S, Ostermeier G, Krawetz S: Profiling Gene Expression Using Onto-Express. Genomics 2002, 79(2):266-270.
8. Bild A, Yao G, Chang J, Wang Q, Potti A, Chasse D, Joshi M, Harpole D, Lancaster J, Berchuck A, Olson J, Marks J, Dressman H, West J M Nevins: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(19):353-357.
9. Khatri P, Draghici S: Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics 2005, 21:3587-3595.
10. Fortunel NO, Otu HH, Ng HH, Chen J, Mu X, Chevassut T, Li X, Joseph M, Bailey C, Hatzfeld JA, et al: author reply 393. Science 2003, 302:393.
11. NJ R: Searching for genetic determinants in the new millennium. Nature 2000, 405:847-856.
12. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 2005, 102:15545-15550.
13. Tian L, Greenberg S, Kong S, Altschuler J, Kohane I, Park P: Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci 2005, 102:13544-13549.
14. Maglietta R, Piepoli A, Catalano D, Licciulli F, Carella M, Liuni S, Pesole G, Perri F, Ancona N: Statistical assessment of functional categories of genes deregulated in pathological conditions by using microarray data. Bioinformatics 2007, 23(16):2063-2072.
15. Creighton CJ: Multiple oncogenis Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors. PLoS ONE 2008, 3(3):e1816.
16. Ancona N, Maglietta R, Piepoli A, D'Addabbo A, Cotugno R, Savino M, Liuni S, Carella M, Pesole G, Perri F: On the statistical assessment of classifiers using DNA microarray data. BMC Bioinformatics 2006, 7:387.
17. Good P: Permutation tests: a practical guide to resampling methods for testing hypotheses. New York: Springer Verlag, New York, Inc 1994.
18. Vapnik V. The Nature of Statistical Learning Theory. New York: Springer Verlag; 1995.
19. Rifkin R, Yeo G, Poggio T. Regularized least squares classification. In: Suykens J, et al, eds. Advances in Learning Theory: Methods, Model and Applications, NATO Science Series III: Computer and Systems Sciences. Amsterdam: IOS Press. 2003:131-153.
20. Ancona N, Maglietta R, D'Addabbo A, Liuni S, Pesole G: Regularized least squares cancer classifiers from DNA microarray data. BMC-Bioinformatics 2005, 6(Suppl 4):S2.
21. Maglietta R, D'Addabbo A, Piepoli A, Perri F, Liuni S, Pesole G, Ancona N: Selection of relevant genes in cancer diagnosis based on their prediction accuracy. Artif Intell Med 2007, 40:29-44.
22. Mukherjee S, Tamayo P, Rogers S, Rifkin R, Engle A, Campbell C, Golub TR, Mesirov JP: Estimating dataset size requirements for classifying DNA microarray data. J Comp Biol 2003, 10:119-142.
23. Michiels S, Koscielny S, Hill C: Predictor of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005, 365:488-492.
24. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE: Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003, 22(41):6408-6423.
25. Hanahan D, Weinberg RA: The Hallmarks of Cancer. Cell 2000, 100:57-70.
26. Mariadason JM, Corner GA, Augenlicht LH: Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 2000, 60(16):4561-4572.
27. Wang A, Arantes S, Conti C, McArthur M, Aldaz CM, MacLeod MC: Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells. Md Carcinog 2007, 46(6):476-487.
28. Yan C, Boyd DD: ATF3 regulates the stability of p53: a link to cancer. Cell Cycle 2006, 5(9):926-929.
29. Zhang C, Gao C, Kawauchi J, Hashimoto Y, Tsuchida N, Kitajima S: Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. Biochemical and Biophysical Research Communications 2002, 297:1302-1310.
30. Lee SH, Kim JS, Yamaguchi K, Eling TE, Baek SJ: Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 2005, 328(1):63-69.
31. Weber MM, Fottner C, Liu SB, Jung MC, Engelhardt D, Baretton GB: Overexpression of the Insulin-Like Growth Factor I Receptor in Human Colon Carcinomas. CANCER 2002, 95(10):2086-2095.
32. Nosho K, Yamamoto H, Taniguchi H, Adachi Y, Yoshida Y, Arimura Y, Endo T, Hinoda Y, Imai K: Interplay of Insulin-Like Growth Factor-II, Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, COX-2, and Matrix Metalloproteinase-7, Play Key Roles in the Early Stage of Colorectal Carcinogenesis. Clinical Cancer Research 2004, 10:7950-7957.
33. Woodson W, Flood A, Green L, Tangrea JA, Hanson J, Cash B, Schatzkin A, Schoenfeld P: Loss of Insulin-Like Growth Factor-II Imprinting and the Presence of Screen-Detected Colorectal Adenomas in Women. Journal of the National Cancer Institute 2004, 96(5):407-410.
34. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Letters. 2003; 194:1-11.
35. Ye S: Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000, 19:623-629.
36. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR: Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 1991, 49:666-672.
37. Jay P, Berta P, Blache P: Expression of the Carcinoembryonic Antigen Gene Is Inhibited by SOX9 in Human Colon Carcinoma Cells. Cancer Res 2005, 65(6):2193-2198.
38. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, Wong CKC: Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer Cells. Endocrinology 2005, 146(11):4951-4960.
39. Bartos JD, Gaile DP, McQuaidb DE, Conroy JM, Darbary H, Nowak NJ, Block A, Petrelli NJ, Mittelman A, Stoler DL, Anderson GR: aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: Coordinate involvement of the regions including BCR and ABL. Mutation Research 2007, 615:1-11.
40. Grabsch H, Dattani M, Barker L, Maughan N, Maude K, Hansen O, Gabbert HE, Quirke P, Mueller W: Expression of DNA Double-Strand Break Repair Proteins ATM and BRCA1 Predicts Survival in Colorectal Cancer. Clin Cancer Res 2006, 12(5):1494-1500.
41. Kim CJ, Lee JH, Song JW, Cho YG, Kim SY, Nam SW, Yoo NJ, Park WS, Lee JY: Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability. EJSO 2007, 33:580-585.
42. Kilpivaara O, Alhopuro P, Vahteristo P, Aaltonen LA, Nevanlinna HJ: CHEK2 I157T associates with familial and sporadic colorectal cancer. Med Genet 2006, 43(7):e34.
43. Garcia V, Garcia JM, Pena C, Silva J, Dominguez G, Rodriguez R, Maximiano C, Espinosa R, Espana P: The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas. J Pathol 2005, 206(1):92-99.
44. Li GQ, Zhang HF. Mad2 and p27 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol. 2004;10(21):3218-3220.
45. Giannini G, Rinaldi C, Ristori E, Ambrosini MI, Cerignoli F, Viel A, Bidoli E, Berni S, D'Amati G, Scambia G, Frati L, Screpanti I, Gulino A: Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability. Oncogene 2004, 23(15):2640-2647.
46. Berndt SI, Platz EA, Fallin MD, Thuita LW, Hoffman SC, Helzlsouer KJ: Mismatch repair polymorphisms and the risk of colorectal cancer. Int J Cancer 2007, 120(7):1548-1554.
47. Uhrhammer N, Bay JO, Gosse-Brun S, Kwiatkowski F, Rio P, Daver A, Bignon YJ: Allelic imbalance at NBS1 is frequent in both proximal and distal colorectal carcinoma. Oncol Rep 2000, 7(2):427-431.
48. Bao S, Chang MS, Auclair D, Sun Y, Wang Y, Wong WK, Zhang J, Liu Y, Qian X, Sutherland R, Magi-Galluzi C, Weisberg E, Cheng EYS, Hao L, Sasaki H, Campbell MS, Kraeft SK, Loda M, Lo KM, Chen LB: HRad17, a Human Homologue of the Schizosaccharomyces pombe Checkpoint Gene rad17, Is Overexpressed in Colon Carcinoma. CANCER RESEARCH 1999, 59:2023-2028.
49. Givalos N, Gakiopoulou H, Skliri M, Bousboukea K, Konstantinidou AE, Korkolopoulou P, Lelouda M, Kouraklis G, Patsouris E, Karatzas G: Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Modern Pathology 2007, 20:159-166.
50. Krajewska WM, Stawinska M, Brys M, Mlynarski W, Witas H, Okruszek A, Kilianska ZM: Genotyping of p53 codon 175 in colorectal cancer. Med Sci Monit 2003, 9(5):228-231.
51. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima S: Annexin II Overexpression Correlates with Stromal Tenascin-C Overexpression. A Prognostic Marker in Colorectal Carcinoma. Cancer 2001, 92:1419-1426.
52. Guzman-Aranguez A, Olmo N, Turnay J, Lecona E, Perez-Ramos P, Lopez de Silanes I, Lizarbe MA: Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J Cell Biochem 2005, 94(1):178-193.
53. OKAZAKI H, MIZUNO M, NASU J, MAKIDONO C, HIRAOKA S, YAMAMOTO K, OKADA H, FUJITA T, TSUJI T, SHIRATORI Y: Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis. J Lab Clin Med 2004, 143(3):169-174.
54. Durrant LG, Chapman MA, Buckley DJ, Spendlove I, Robins RA, Armitage NC: Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother 2003, 52:638-642.
55. Iwagaki N, Mizuno M, Nasu J, Mizuno M, Okazaki H, Hori S, Yamamoto K, Okada H, Tsuji T, Fujita T, Shiratori Y: Advances in the development of a reliable assay for the measurement of stool decay-accelerating factor in the detection of colorectal cancer. J Immunoassay Immunochem 2002, 23(4):497-507.
56. Mizuno M, Mizuno M, Iwagaki N, Nasu J, Okazaki H, Yamamoto K, Okada H, Tsuji T, Fujita T, Shiratori Y: Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer. Am J Gastroenterol 2003, 98(11):2550-2555.
57. Nakagawa M, Mizuno M, Kawada M, Uesu T, Nasu J, Takeuchi K, Okada H, Endo Y, Fujita T, Tsuji T: Polymorphic expression of decay-accelerating factor in human colorectal cancer. J Gastroenterol Hepatol 2001, 16(2):184-189.
58. Elzagheid A, Algars A, Bendardaf R, Lamlum H, Ristamaki R, Collan Y, Syrjanen K, Pyrhonen S: E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol 2006, 12(27):4304-4309.
59. Furuta K, Yoshioka S, Okabe S, Ikeda M, Oginosawa M, Ikeda S, Nakayama Y, Kikuchi M, Hamilton SR: Expressions of two adenomatous polyposis coli and E-cadherin proteins on human colorectal cancers. Virchows Arch 2003, 442(3):266-270.
60. Skrzydlewska E, Kozuszko B, Sulkowska M, Bogdan Z, Kozlowski M, Snarska J, Puchalski Z, Sulkowski S, Skrzydlewski Z: Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology 2003, 50(49):126-131.
61. Park KA, Byun HS, Won M, Yang KJ, Shin S, Piao L, Kim JM, Yoon WH, Junn E, Park J, H SJ, Hur GM: Sustained activation of protein kinase C downregulates nuclear factor-kB signaling by dissociation of IKK-g and Hsp90 complex in human colonic epithelial cells. Carcinogenesis 2007, 28(1):71-80.
62. Cen H, Zheng S, Fang YM, Tang XP, Dong Q: Induction of HSF1 expression is associated with sporadic colorectal cancer. World J Gastroenterol 2004, 10(21):3122-3126.
63. Greco C, Alvino S, Buglioni S, Assisi D, Lapenta R, Grassi A, Stigliano V, Mottolese M, Casale V: Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Anticancer Res 2001, 21(5):3185-3192.
64. Seidler HBK, Utsuyama M, Nagaoka S, Takemura T, Kitagawa M, Hirokawa K: Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups. Experimental and Molecular Pathology 2004, 76:224-233.
65. Han J, Xia C, Gao J, Xing C, Yang X, Tang X, Qiu F, Du Y: Expression of vascular endothelial growth factor in colorectal cancer and its clinical significance. Zhonghua Yi Xue Za Zhi 2002, 82(7):481-483.
66. Pellizzaro C, Coradini D, Dandone MG: Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis 2002, 23(5):735-740.
67. Faviana P, Boldrini L, Spisni R, Berti P, Galleri D, Biondi R, Camacci T, Materazzi G, Pingitore R, Miccoli P, Fontanini G: Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression. Oncol Rep 2002, 9(3):617-620.
68. Cassano A, Bagala C, Battelli C, Schinzari G, Quirino M, Ratto C, Landriscina M, Barone C: Expression of vascular endothelial growth factor, mitogen-activated protein kinase and p53 in human colorectal cancer. Anticancer Res 2002, 22(4):2179-2184.
69. Edelman E, Guinney J, Chi J, Febbo P, S M: Modeling cancer progression via pathway dependencies. PLoS Comput Biol 2008, 4(2):e28.